Skip to content

Efficacy of non-surgical treatment in patients with inflammation around teeth and implants without bone loss.

Efficacy of Non-surgical Treatment in patients with Gingivitis and Peri-implant Mucositis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3csfjq
Enrollment
Unknown
Registered
2020-02-27
Start date
2019-05-06
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal disease, unspecified

Interventions

Longitudinal prospective, controlled, randomized, double blind clinical trial. Patients in this study will be allocated to two groups that will receive non-surgical treatment, 28 patients will receive
Drug

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Universidade Federal do Rio Grande do Norte
Collaborator
Departamento de Odontologia da Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Present clinical diagnosis of mucositis peri implant, i.e., present probing depth of up to 5 mm, bleeding to the probing without evidence of radiographic bone loss in addition to the first two threads of implants; Be rehabilitated with unitary prosthesis, protocol or overdenture; Be partially or totally toothless; individuals who have been rehabilitated for at least 1 year. For cases of gingivitis, present clinical diagnosis of gingivitis in intact periodont, i.e., present probing depth less than or equal to 3 mm, 10% or more of sites with bleeding to the probing, absence of loss of insertion and bone loss Radiographic Patients presenting sites with probing depth of up to 3 mm, 10% or more of sites with bleeding to the probing, loss of insertion and possible radiographic bone loss; Patients with a history of treatment of periodontitis, therefore, presenting loss of insertion, sites with periodontal pouch of up to 3 mm, 10% or more of sites with bleeding to the probing and radiographic bone loss.

Exclusion criteria

Exclusion criteria: o present systemic complications, such as cardiovascular diseases, Alzheimer's, lung diseases, cerebral or metabolic syndromes;Have used antibiotics, anti-inflammatories, immunosuppressants or periodontal treatment in the last 6 months prior to the survey;Individuals who are in the gestational or breastfeeding period;Individuals who use orthodontic appliances.

Design outcomes

Primary

MeasureTime frame
It is expected to find a decrease in inflammation in the peri-implant region, verified by the periodontal probing method, from the decrease in bleeding on probing.

Secondary

MeasureTime frame
It is expected to reduce probing depth and probing bleeding by the periodontal probing method before and after intervention.;The amount of periodontopathogenic bacteria is expected to be reduced by the real time PCR method.

Countries

Brazil

Contacts

Public ContactGuilherme Freire

Departamento de Odontologia da Universidade Federal do Rio Grande do Norte

guilherme.beiruth@gmail.com+55(84)999663503

Outcome results

None listed

Source: REBEC (via WHO ICTRP)